What do GLP-1 receptor agonists actually do?
GLP-1 (glucagon-like peptide-1) is an incretin hormone your gut releases after eating. It signals satiety to the brain, slows gastric emptying, and modulates insulin release. GLP-1 receptor agonists are a class of medications that mimic this hormone at the receptor level — producing prolonged satiety signaling, reduced appetite, and slower gastric emptying at doses higher than the body produces naturally.
The clinical research on this class is substantial. Long-term trials have documented meaningful weight reduction and improvements in cardiovascular risk markers in patients without diabetes. The mechanism is pharmacological, not motivational — these drugs change the neurohormonal environment that drives hunger.
Do OTC “GLP-1 alternatives” actually work?
Before discussing legitimate clinician-prescribed options, it’s worth being direct about what doesn’t belong in the same category.
OTC GLP-1 patches, “natural semaglutide,” berberine-as-Ozempic marketing, and dietary supplements claiming to “boost GLP-1” are not GLP-1 receptor agonists. They do not bind to GLP-1 receptors with the affinity or duration required to produce the clinical effects seen in trials. Some may influence appetite through other mechanisms, but the framing that positions them as interchangeable with prescription GLP-1 therapy is misleading.
If you’ve seen aggressive marketing for any of these products, the red-flag list is short: no published randomized controlled trial, no FDA approval or accepted compounding pathway, no licensed prescriber in the chain. The legitimate path to GLP-1 receptor agonist therapy runs through a licensed clinician. Full stop.
What is compounded semaglutide?
Compounded semaglutide is prepared by a licensed 503A compounding pharmacy in the USA for one patient, against a prescription that names that patient. It contains the same active molecule as the branded injectables and is a different product: the pharmacy prepares it to the specifications the prescribing clinician sets, including the dose and, often, what else is in the vial.
Compounded semaglutide is not FDA-approved. The branded shortages that dominated coverage of this category a few years ago were resolved by FDA. A prescription written for you by a licensed clinician is what a 503A pharmacy fills.
At PepScribe, compounded semaglutide is prepared by licensed 503A pharmacies in the USA. No hidden overseas supply chain. All formulations are prepared by licensed compounders under 503A oversight — never 503B, never international.
How is compounded tirzepatide different?
Tirzepatide is the active molecule in branded injectable weight management products. It differs from semaglutide in that it acts as a dual GIP (glucose- dependent insulinotropic polypeptide) and GLP-1 receptor agonist — activating two incretin pathways simultaneously. Published head-to-head trials have documented greater average weight reduction with tirzepatide versus semaglutide at the doses studied, though individual response varies.
Compounded tirzepatide comes from licensed 503A pharmacies in the USA on the same terms as compounded semaglutide: a patient-specific prescription, a dose set by the clinician, and a preparation that is not FDA-approved. PepScribe’s is a tirzepatide and cyanocobalamin combination. The choice between semaglutide and tirzepatide is a clinical decision based on your history, goals, tolerance profile, and current formulary availability. A clinician makes that call, not a landing page.
What should you evaluate when comparing GLP-1 alternatives?
If you’re comparing options, the questions that actually matter are:
- Is there a licensed prescriber in the chain? No legitimate GLP-1 therapy reaches you without a prescription from a licensed clinician who has reviewed your health history.
- Where is the medication compounded? It should be prepared by a licensed 503A pharmacy in the USA. Ask specifically — not “packaged in the USA” or “US-sourced ingredients,” but compounded in the USA by a 503A facility.
- What is actually in the vial? Compounded GLP-1 preparations are frequently combinations, such as the molecule with cyanocobalamin, at a dose written for you. Ask what yours contains and at what strength before committing to a program.
- Is there ongoing clinical oversight? Weight management therapy is not a supplement you add to your routine. It requires monitoring, dose adjustment, and management of potential side effects by a qualified clinician.
- What does the program actually include? A responsible program bundles the clinical consultation, the prescription, the pharmacy fulfillment, and follow-up check-ins — not just a monthly shipment.
Is sermorelin a GLP-1 alternative?
Sermorelin is sometimes discussed alongside GLP-1 alternatives in the context of body composition. It is not a GLP-1 receptor agonist and does not work the same way. Sermorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary to release growth hormone through a natural pulsatile pattern.
Some patients pursuing weight management and body composition goals use both a GLP-1 therapy and a GHRH analog, but they serve different functions in the endocrine system. Sermorelin is a Category 1 peptide available through licensed 503A compounding pharmacies with a clinician’s prescription. You can read more on the Sermorelin program page if this is part of your interest.
Frequently asked questions
What are the main GLP-1 alternatives to branded injectables?
The primary clinician-prescribed alternatives are compounded semaglutide and compounded tirzepatide prepared by licensed 503A compounding pharmacies in the USA. These use the same active molecules as branded GLP-1 drugs but are not FDA-approved drug products; they are customized preparations prescribed by a licensed clinician for individual patients.
Is compounded semaglutide the same as Ozempic or Wegovy?
Compounded semaglutide contains semaglutide as the active ingredient, the same molecule used in branded products. However, compounded semaglutide is not the same product as Ozempic or Wegovy — it is not FDA-approved, and it is not manufactured by the same process. Never assume compounded and branded products are interchangeable without clinician guidance.
Are GLP-1 patches or supplements real alternatives?
No. OTC "GLP-1 patches," "natural GLP-1 supplements," and similar products are not prescription GLP-1 receptor agonists and have no published evidence that they replicate the mechanism of injectable GLP-1 therapies. The only evidence-backed path to GLP-1 receptor agonist therapy is through a licensed clinician with a valid prescription.
Who determines whether semaglutide or tirzepatide is right for me?
A licensed clinician reviews your health history, goals, and any contraindications before recommending any weight management therapy. Neither semaglutide nor tirzepatide is appropriate for all patients, and the choice between them depends on individual clinical factors.
Are compounded GLP-1 therapies available right now?
Compounded GLP-1 preparations are prescription medications, so the answer for any one person comes out of a clinician review. A licensed clinician looks at your history and eligibility, and where a GLP-1 preparation is appropriate the prescription goes to a licensed 503A pharmacy in the USA to be compounded for you. Compounded preparations are not FDA-approved.
